A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Kimmerling RJ, Stevens MM, Olcum S, Minnah A, Vacha M, LaBella R, Ferri M, Wasserman SC, Fujii J, Shaheen Z, Sundaresan S, Ribadeneyra D, Jayabalan DS, Agte S, Aleman A, Criscitiello JA, Niesvizky R, Luskin MR, Parekh S, Rosenbaum CA, Tamrazi A, Reid CA.
Kimmerling RJ, et al. Among authors: stevens mm.
Commun Biol. 2022 Nov 26;5(1):1295. doi: 10.1038/s42003-022-04270-3.
Commun Biol. 2022.
PMID: 36435843
Free PMC article.